The Megyn Kelly Show cover image

A Deep Dive Into Alzheimer's and Disturbing New Scientific Findings, with Dr. Dale Bredesen, Dr. Matthew Schrag, and Charles Piller | Ep. 373

The Megyn Kelly Show

00:00

Navigating Alzheimer's Drug Controversies

This chapter features a medical expert discussing the complexities surrounding Alzheimer's treatment, particularly the controversial FDA approval of the drug Aducanumab. The conversation highlights the importance of truth in medical research, addressing the implications of drug effectiveness and the ongoing debate about amyloid plaques in Alzheimer's disease.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app